Page 66 - Read Online

Jaeger L, Kassell N, Kongable‑Beckman G, Torner JC; International 17. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Egashira K, Hashimoto N.
Study of Unruptured Intracranial Aneurysms Investigators. Impact of monocyte chemoattractant protein‑1 deficiency on
Unruptured intracranial aneurysms: natural history, clinical cerebral aneurysm formation. Stroke 2009;40:942‑51.
outcome, and risks of surgical and endovascular treatment. Lancet 18. Kondo S, Hashimoto N, Kikuchi H, Hazama F, Nagata I, Kataoka H.
2003;362:103‑10. Apoptosis of medial smooth muscle cells in the development of
2. UCAS Japan Investigators, Morita A, Kirino T, Hashi K, Aoki N, saccular cerebral aneurysms in rats. Stroke 1998;29:181‑8.
Fukuhara S, Hashimoto N, Nakayama T, Sakai M, Teramoto A, 19. Sadamasa N, Nozaki K, Hashimoto N. Disruption of gene for
Tominari S, Yoshimoto T. The natural course of unruptured cerebral inducible nitric oxide synthase reduces progression of cerebral
aneurysms in a Japanese cohort. N Engl J Med 2012;366:2474‑82. aneurysms. Stroke 2003;34:2980‑4.
3. Sonobe M, Yamazaki T, Yonekura M, Kikuchi H. Small unruptured 20. Moriwaki T, Takagi Y, Sadamasa N, Aoki T, Nozaki K,
intracranial aneurysm verification study: SUAVe study, Japan. Stroke Hashimoto N. Impaired progression of cerebral aneurysms in
2010;41:1969‑77. interleukin‑1beta‑deficient mice. Stroke 2006;37:900‑5.
4. Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R. 21. Jayaraman T, Berenstein V, Li X, Mayer J, Silane M, Shin YS,
Structural fragility and inflammatory response of ruptured cerebral Niimi Y, Kiliç T, Gunel M, Berenstein A. Tumor necrosis factor
aneurysms. A comparative study between ruptured and unruptured alpha is a key modulator of inflammation in cerebral aneurysms.
cerebral aneurysms. Stroke 1999;30:1396‑401. Neurosurgery 2005;57:558‑64.
5. Satta J, Haukipuro K, Kairaluoma MI, Juvonen T. Aminoterminal 22. Ruigrok YM, Tan S, Medic J, Rinkel GJ, Wijmenga C. Genes involved
propeptide of type III procollagen in the follow‑up of patients with in the transforming growth factor beta signalling pathway and
abdominal aortic aneurysms. J Vasc Surg 1997;25:909‑15. the risk of intracranial aneurysms. J Neurol Neurosurg Psychiatry
6. Schouten O, van Laanen JH, Boersma E, Vidakovic R, Feringa HH, 2008;79:722‑4.
Dunkelgrün M, Bax JJ, Koning J, van Urk H, Poldermans D. Statins 23. Yokoi T, Isono T, Saitoh M, Yoshimura Y, Nozaki K. Suppression of
are associated with a reduced infrarenal abdominal aortic aneurysm cerebral aneurysm formation in rats by a tumor necrosis factor‑a
growth. Eur J Vasc Endovasc Surg 2006;32:21‑6. inhibitor. J Neurosurg 2014;120:1193‑200.
7. Dobrin PB, Mrkvicka R. Failure of elastin or collagen as possible 24. Jayaraman T, Paget A, Shin YS, Li X, Mayer J, Chaudhry H,
critical connective tissue alterations underlying aneurysmal Niimi Y, Silane M, Berenstein A. TNF‑alpha‑mediated inflammation
dilatation. Cardiovasc Surg 1994;2:484‑8. in cerebral aneurysms: a potential link to growth and rupture. Vasc
8. Knox JB, Sukhova GK, Whittemore AD, Libby P. Evidence for altered Health Risk Manag 2008;4:805‑17.
balance between matrix metalloproteinases and their inhibitors in 25. Sibson NR, Blamire AM, Perry VH, Gauldie J, Styles P, Anthony DC.
human aortic diseases. Circulation 1997;95:205‑12. TNF‑alpha reduces cerebral blood volume and disrupts tissue
9. Thompson RW, Parks WC. Role of matrix metalloproteinases in homeostasis via an endothelin‑ and TNFR2‑dependent pathway.
abdominal aortic aneurysms. Ann N Y Acad Sci 1996;800:157‑74. Brain 2002;125:2446‑59.
10. Basso F, Lowe GD, Rumley A, McMahon AD, Humphries SE. 26. Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ,
Interleukin‑6 ‑174G>C polymorphism and risk of coronary heart Carpenter MK, Holtsberg F, Mattson M. Altered neuronal and
disease in West of Scotland coronary prevention study (WOSCOPS). microglial responses to excitotoxic and ischemic brain injury in mice
Arterioscler Thromb Vasc Biol 2002;22:599‑604. lacking TNF receptors. Nat Med 1996;2:788‑94.
11. Shimizu K, Mitchell RN, Libby P. Inflammation and cellular immune 27. Turrin N, Rivest S. Tumor necrosis factor alpha but not interleukin
responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc 1 beta mediates neuroprotection in response to acute nitric oxide
Biol 2006;26:987‑94. excitotoxicity. J Neurosci 2006;26:143‑51.
12. Hashimoto T, Meng H, Young WL. Intracranial aneurysms: links 28. Shohami E, Ginis I, Hallenbeck JM. Dual role of tumor necrosis
among inflammation, hemodynamics and vascular remodeling. factor alpha in brain injury. Cytokine Growth Factor Rev
Neurol Res 2006;28:372‑80. 1999;10:119‑30.
13. Chyatte D, Bruno G, Desai S, Todor DR. Inflammation and 29. Ruigrok YM, Elias R, Wijmenga C, Rinkel GJ. A comparison of
intracranial aneurysms. Neurosurgery 1999;45:1137‑46. genetic chromosomal loci for intracranial, thoracic aortic, and
14. Gaetani P, Grazioli V, Tancioni F, Casari E, Tartara F, abdominal aortic aneurysms in search of common genetic risk
Rodriguezy Baena R. Abnormalities of collagen cross‑linkage in factors. Cardiovasc Pathol 2008;17:40‑7.
posterior communicating artery aneurysms: a preliminary study. 30. Kataoka K, Taneda M, Asai T, Yamada Y. Difference in nature
Neurol Res 1996;18:541‑5. of ruptured and unruptured cerebral aneurysms. Lancet
15. Gaetani P, Rodriguez y Baena R, Tartara F, Messina AL, Tancioni F, 2000;355:203.
Schiavo R, Grazioli V. Metalloproteases and intracranial vascular
lesions. Neurol Res 1999;21:385‑90. Cite this article as: Yokoi T, Saito M, Yoshimura Y, Tsuji K, Nozaki K. Cerebral
16. Aoki T, Kataoka H, Shimamura M, Nakagami H, Wakayama K, aneurysms and inflammation. Neuroimmunol Neuroinflammation 2015;2(2):55-8.
Moriwaki T, Ishibashi R, Nozaki K, Morishita R, Hashimoto N. Source of Support: Nil. Conflict of Interest: No.
NF‑kappaB is a key mediator of cerebral aneurysm formation.
Circulation 2007;116:2830‑40. Received: 10-09-2014; Accepted: 30-09-2014

58 Neuroimmunol Neuroinflammation | Volume 2 | Issue 2 | April 15, 2015